ArticleTurkish journal of urology2015

Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study.

Selçuk Altın et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.